Press-release for stocks related to covid for NOVN

Prices are updated after-hours

Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M

| -98.65% | O: -2.23% H: 0.0% C: 0.0%
covid treatment preclinical covid-19 pre-clinical

Novan Announces Positive Preclinical Data in SB019 COVID-19 Anti-Viral Therapy Program
Published: 2021-06-10 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M

| -98.94% | O: 3.84% H: 8.15% C: -1.74%
covid positive therapy antiviral preclinical covid-19 pre-clinical

Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
Published: 2020-12-21 (Crawled : 14:03) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M

| -86.28% | O: 10.22% H: 0.53% C: -10.19%
covid covid-19 program

Novan Announces Data from B-SIMPLE Week 24 Safety Evaluation and COVID-19 Business Updates
Published: 2020-03-23 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M

| -82.89% | O: 0.22% H: 36.07% C: 12.75%
covid covid-19

75%

25%

MTTR | News M | $4.78 174.71% 63.6% 72M

AGBA | $2.565 105.2% 51.27% 200M

MLEC | $2.44 74.29% 42.62% 78M

EDBL | News | $6.28 67.02% 40.13% 16M

ATGL | $2.91 48.81% 32.8% 180K

ZAPP | $0.2175 47.16% 32.05% 16M

ONFO | $0.6075 38.38% 27.74% 7.3M

VIVK | $1.48 38.32% 27.7% 530K

MNTS | $0.5 35.69% 26.3% 4.8M

SDIG A | $3.635 35.13% 26.0% 1M

Save your searches and get alerts when important news are released.